- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07524465
Mochida ReFeel für digitale Nervenverletzungen
Untersuchungsleitergeführtes Beobachtungs-Klinikforschungsprojekt zur Bewertung der Auswirkungen des ReFeel bei digitalen Nervenverletzungen.
This is an Investigator Led single-center, Prospective and Observational, Clinical Research Project. The specific aim of this study is to test/observe the safety and effectiveness of the ReFeel Device for Digital nerve injury in improving recovery time and outcomes. The primary objective of this study is to monitor clinical and surgical procedural outcomes for the use of ReFeel device.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.
ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.
Despite this common injury there is continued debate on the best treatment algorithm for digital nerve injuries. Digital nerve repair is usually not an option as the field of injury is too large for direct repair. Both conduits and nerve allograft have been used with varying success. Nerve conduits have traditionally been used for gaps less than 2 cm, with allograft for larger gaps.
ReFeel has received 510(k) clearance for a new alginate-based nerve cuff. We propose to conduct an Investigator-led Observational Clinical Research of ReFeel for patients treated with alginate nerve cuff to assess the clinical function following reconstruction.
Studientyp
Einschreibung (Geschätzt)
Phase
- Phase 4
Kontakte und Standorte
Studienorte
-
-
North Carolina
-
Charlotte, North Carolina, Vereinigte Staaten, 28207
- OrthoCarolina Research Institute
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 18-69 years
- Digital nerve injury in at least one digit requiring repair with a gap of 1-25mm
- Able to provide tension free end to end nerve coaptation
- Have uninjured contralateral or adjacent digit that is suitable to serve as a referenced digit for baseline functional assessments.
- Willing to comply with follow up for visits up to 12 months.
Exclusion Criteria:
- Estimated distance of recovery greater than 150 mm (from proximal site of to the tip of the digit)
- Injury distal to distal interphalangeal joint
- Extensive soft tissue injury that will impair recovery assessment
- Incomplete nerve transections
- Injury requiring replantation of the target digit
- Injuries to the affected nerve proximal to the superficial arch
- Nerve injuries > 24 weeks after initial injury
- End to side nerve repair
- Injuries with vascular damage resulting in inadequate perfusion despite repair
- Subjects with type 1 diabetes or type 2 diabetes requiring regular insulin therapy
- Subjects who are undergoing or expected to undergo treatment with chemotherapy, radiation therapy, or other know treatment that affects the growth of neural and/or vascular system
- History of neuropathy, diabetic neuropathy, or another known neuropathy
- Excepted use of medication during the study that is known to impact nerve regeneration or cause peripheral neuropathy such as immunosuppressant's and Chemotherapeutic
- History of chronic ischemic condition of the upper extremity.
- Workers Compensation
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Sonstiges: ReFeel device
Subjects who enroll in this study will receive ReFeel device for Digital nerve injury |
ReFeel is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue. ReFeel is a device used in applications for patients with peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from Baseline in Static two-point discrimination
Zeitfenster: Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
|
Presented in millimetres and in ASSH designation (less than 6 mm 'normal', 6-10 mm 'fair', and 11 to 15 mm 'poor') |
Baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Visual Analog Scale (VAS)
Zeitfenster: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Pain Score (1-10, 1 being the best and 10 being the worst pain) |
Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
|
Water emersion testing
Zeitfenster: 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Recommend patients submerge injured hand into water until other digits wrinkle. Report weekly if finger wrinkles like non-injured digits. |
2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
|
Physician Satisfaction Score
Zeitfenster: Operative
|
Scale 0-5, with 0 being very difficult and 5 being very Easy the best score |
Operative
|
|
How many nerves were repaired with the provided graft sheet?
Zeitfenster: Operative
|
How many nerves were repaired with the provided graft sheet? |
Operative
|
|
Change in Range of Motion (ROM)
Zeitfenster: Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Change in Range of Motion (ROM) of the injured digit, measured in degrees, from baseline |
Baseline, 2 weeks, 6 weeks, 12 weeks, 3 months, 6 months, 12 months
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Glenn Gaston, MD, OrthoCarolina Research Institute
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 9220 (ReFeel - 0001)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
To be determined at a later date.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .